Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review Article Swipe
Mende Mensa Sorato
,
Majid Davari
,
Abbas Kebriaeezadeh
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1177/27550834241236598
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1177/27550834241236598
Background: Both constrained access to essential medicines and combatting marketing of substandard and falsified (SF) medicines are unmet health sector goals in Africa. Objective: To answer the question of how improved access can reduce the continuous surge of SF medicines in Africa. Design: We conducted a scoping review based on standard protocol. Methods: We searched articles published in the English language from PubMed/Medline, Cochrane Library, Embase, Scopus, Web of Science, and Google Scholar by using a systematic search query. Results: Seventy-one articles were included in this review. Access to quality essential medicines is still a major problem in developing countries in Africa and will continue as a threat for the next decade of health care. Ensuring access to quality medicines and preventing SF medicines in Africa need a systematic approach to address their underlying causes. Failure to ensure access to medicines is the major reason for the availability of SF medicines. Improving access to quality medicines can reduce SF medicine marketing and use. Manipulating the entire supply chain for efficiency, avoiding trade agreements that could reduce access, using compulsory licensing provisions, and pharmaceutical price control, providing incentives for drug development, and promoting rational use of medicines can improve access. Conclusion: Ensuring access to medicines and preventing SF medicine marketing cannot be achieved in the planned period in developing countries in Africa unless a comprehensive strategy is used. Improving access to quality medicines can reduce SF medicine marketing and use, that is, ensuring access through uninterrupted supply, improved efficiency, enhanced local production, preventing SF medicine entry, improved medication use system, and improved affordability. Therefore, it is essential to improve supply chain capability, address challenges of the supply chain, improve leadership and governance, establish country-specific anti-counterfeiting and anti-substandardization committees, and collaborate with all relevant stakeholders.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/27550834241236598
- https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598
- OA Status
- hybrid
- Cited By
- 6
- References
- 104
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392666024
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392666024Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/27550834241236598Digital Object Identifier
- Title
-
Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping reviewWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-01Full publication date if available
- Authors
-
Mende Mensa Sorato, Majid Davari, Abbas KebriaeezadehList of authors in order
- Landing page
-
https://doi.org/10.1177/27550834241236598Publisher landing page
- PDF URL
-
https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598Direct OA link when available
- Concepts
-
Access to medicines, Market access, Incentive, Quality (philosophy), Business, Medicine, Essential medicines, Scopus, MEDLINE, Developing country, Marketing, Economic growth, Public health, Nursing, Political science, Economics, Biology, Law, Ecology, Epistemology, Philosophy, Microeconomics, AgricultureTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6Per-year citation counts (last 5 years)
- References (count)
-
104Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392666024 |
|---|---|
| doi | https://doi.org/10.1177/27550834241236598 |
| ids.doi | https://doi.org/10.1177/27550834241236598 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38476401 |
| ids.openalex | https://openalex.org/W4392666024 |
| fwci | 5.99805483 |
| type | article |
| title | Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review |
| biblio.issue | |
| biblio.volume | 8 |
| biblio.last_page | 27550834241236598 |
| biblio.first_page | 27550834241236598 |
| topics[0].id | https://openalex.org/T11792 |
| topics[0].field.id | https://openalex.org/fields/20 |
| topics[0].field.display_name | Economics, Econometrics and Finance |
| topics[0].score | 0.9986000061035156 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2002 |
| topics[0].subfield.display_name | Economics and Econometrics |
| topics[0].display_name | Pharmaceutical Economics and Policy |
| topics[1].id | https://openalex.org/T12878 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9975000023841858 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Pharmaceutical Quality and Counterfeiting |
| topics[2].id | https://openalex.org/T10856 |
| topics[2].field.id | https://openalex.org/fields/14 |
| topics[2].field.display_name | Business, Management and Accounting |
| topics[2].score | 0.9843000173568726 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1405 |
| topics[2].subfield.display_name | Management of Technology and Innovation |
| topics[2].display_name | Intellectual Property and Patents |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3019492093 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5956381559371948 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q29468924 |
| concepts[0].display_name | Access to medicines |
| concepts[1].id | https://openalex.org/C2777481183 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5863569974899292 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q6770787 |
| concepts[1].display_name | Market access |
| concepts[2].id | https://openalex.org/C29122968 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5542864799499512 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1414816 |
| concepts[2].display_name | Incentive |
| concepts[3].id | https://openalex.org/C2779530757 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5319911241531372 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1207505 |
| concepts[3].display_name | Quality (philosophy) |
| concepts[4].id | https://openalex.org/C144133560 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5196946263313293 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[4].display_name | Business |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.5173927545547485 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C2777424817 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4797738492488861 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q35456 |
| concepts[6].display_name | Essential medicines |
| concepts[7].id | https://openalex.org/C83867959 |
| concepts[7].level | 3 |
| concepts[7].score | 0.45944440364837646 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q371467 |
| concepts[7].display_name | Scopus |
| concepts[8].id | https://openalex.org/C2779473830 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4533006250858307 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1540899 |
| concepts[8].display_name | MEDLINE |
| concepts[9].id | https://openalex.org/C83864248 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4206416606903076 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q177323 |
| concepts[9].display_name | Developing country |
| concepts[10].id | https://openalex.org/C162853370 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3643922805786133 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q39809 |
| concepts[10].display_name | Marketing |
| concepts[11].id | https://openalex.org/C50522688 |
| concepts[11].level | 1 |
| concepts[11].score | 0.18877935409545898 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q189833 |
| concepts[11].display_name | Economic growth |
| concepts[12].id | https://openalex.org/C138816342 |
| concepts[12].level | 2 |
| concepts[12].score | 0.1685681939125061 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q189603 |
| concepts[12].display_name | Public health |
| concepts[13].id | https://openalex.org/C159110408 |
| concepts[13].level | 1 |
| concepts[13].score | 0.1319713592529297 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[13].display_name | Nursing |
| concepts[14].id | https://openalex.org/C17744445 |
| concepts[14].level | 0 |
| concepts[14].score | 0.12998080253601074 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[14].display_name | Political science |
| concepts[15].id | https://openalex.org/C162324750 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[15].display_name | Economics |
| concepts[16].id | https://openalex.org/C86803240 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[16].display_name | Biology |
| concepts[17].id | https://openalex.org/C199539241 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[17].display_name | Law |
| concepts[18].id | https://openalex.org/C18903297 |
| concepts[18].level | 1 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q7150 |
| concepts[18].display_name | Ecology |
| concepts[19].id | https://openalex.org/C111472728 |
| concepts[19].level | 1 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q9471 |
| concepts[19].display_name | Epistemology |
| concepts[20].id | https://openalex.org/C138885662 |
| concepts[20].level | 0 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[20].display_name | Philosophy |
| concepts[21].id | https://openalex.org/C175444787 |
| concepts[21].level | 1 |
| concepts[21].score | 0.0 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q39072 |
| concepts[21].display_name | Microeconomics |
| concepts[22].id | https://openalex.org/C118518473 |
| concepts[22].level | 2 |
| concepts[22].score | 0.0 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q11451 |
| concepts[22].display_name | Agriculture |
| keywords[0].id | https://openalex.org/keywords/access-to-medicines |
| keywords[0].score | 0.5956381559371948 |
| keywords[0].display_name | Access to medicines |
| keywords[1].id | https://openalex.org/keywords/market-access |
| keywords[1].score | 0.5863569974899292 |
| keywords[1].display_name | Market access |
| keywords[2].id | https://openalex.org/keywords/incentive |
| keywords[2].score | 0.5542864799499512 |
| keywords[2].display_name | Incentive |
| keywords[3].id | https://openalex.org/keywords/quality |
| keywords[3].score | 0.5319911241531372 |
| keywords[3].display_name | Quality (philosophy) |
| keywords[4].id | https://openalex.org/keywords/business |
| keywords[4].score | 0.5196946263313293 |
| keywords[4].display_name | Business |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.5173927545547485 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/essential-medicines |
| keywords[6].score | 0.4797738492488861 |
| keywords[6].display_name | Essential medicines |
| keywords[7].id | https://openalex.org/keywords/scopus |
| keywords[7].score | 0.45944440364837646 |
| keywords[7].display_name | Scopus |
| keywords[8].id | https://openalex.org/keywords/medline |
| keywords[8].score | 0.4533006250858307 |
| keywords[8].display_name | MEDLINE |
| keywords[9].id | https://openalex.org/keywords/developing-country |
| keywords[9].score | 0.4206416606903076 |
| keywords[9].display_name | Developing country |
| keywords[10].id | https://openalex.org/keywords/marketing |
| keywords[10].score | 0.3643922805786133 |
| keywords[10].display_name | Marketing |
| keywords[11].id | https://openalex.org/keywords/economic-growth |
| keywords[11].score | 0.18877935409545898 |
| keywords[11].display_name | Economic growth |
| keywords[12].id | https://openalex.org/keywords/public-health |
| keywords[12].score | 0.1685681939125061 |
| keywords[12].display_name | Public health |
| keywords[13].id | https://openalex.org/keywords/nursing |
| keywords[13].score | 0.1319713592529297 |
| keywords[13].display_name | Nursing |
| keywords[14].id | https://openalex.org/keywords/political-science |
| keywords[14].score | 0.12998080253601074 |
| keywords[14].display_name | Political science |
| language | en |
| locations[0].id | doi:10.1177/27550834241236598 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4220650896 |
| locations[0].source.issn | 2755-0834 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2755-0834 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Journal of Medicine Access |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Journal of Medicine Access |
| locations[0].landing_page_url | https://doi.org/10.1177/27550834241236598 |
| locations[1].id | pmid:38476401 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | The journal of medicine access |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38476401 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10929061 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10929061/pdf/10.1177_27550834241236598.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Med Access |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10929061 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5069670534 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6342-0980 |
| authorships[0].author.display_name | Mende Mensa Sorato |
| authorships[0].countries | IQ |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2801278263 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacy, College of Medicine, Komar University of Science and Technology, Sulaimaniyah, Iraq |
| authorships[0].institutions[0].id | https://openalex.org/I2801278263 |
| authorships[0].institutions[0].ror | https://ror.org/05azws991 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I2801278263 |
| authorships[0].institutions[0].country_code | IQ |
| authorships[0].institutions[0].display_name | Komar University of Science and Technology |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mende Mensa Sorato |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Pharmacy, College of Medicine, Komar University of Science and Technology, Sulaimaniyah, Iraq |
| authorships[1].author.id | https://openalex.org/A5108100194 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Majid Davari |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I70640408 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran |
| authorships[1].institutions[0].id | https://openalex.org/I70640408 |
| authorships[1].institutions[0].ror | https://ror.org/01c4pz451 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I70640408 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Tehran University of Medical Sciences |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Majid Davari |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran |
| authorships[2].author.id | https://openalex.org/A5078712152 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3872-2474 |
| authorships[2].author.display_name | Abbas Kebriaeezadeh |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I70640408 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran |
| authorships[2].institutions[0].id | https://openalex.org/I70640408 |
| authorships[2].institutions[0].ror | https://ror.org/01c4pz451 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I70640408 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Tehran University of Medical Sciences |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Abbas Kebriaeezadeh |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11792 |
| primary_topic.field.id | https://openalex.org/fields/20 |
| primary_topic.field.display_name | Economics, Econometrics and Finance |
| primary_topic.score | 0.9986000061035156 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2002 |
| primary_topic.subfield.display_name | Economics and Econometrics |
| primary_topic.display_name | Pharmaceutical Economics and Policy |
| related_works | https://openalex.org/W3014476556, https://openalex.org/W4388222904, https://openalex.org/W2606616691, https://openalex.org/W2909964439, https://openalex.org/W2716583231, https://openalex.org/W3000585251, https://openalex.org/W4389206045, https://openalex.org/W2911944620, https://openalex.org/W1955061866, https://openalex.org/W2555392091 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1177/27550834241236598 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4220650896 |
| best_oa_location.source.issn | 2755-0834 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2755-0834 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | The Journal of Medicine Access |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | The Journal of Medicine Access |
| best_oa_location.landing_page_url | https://doi.org/10.1177/27550834241236598 |
| primary_location.id | doi:10.1177/27550834241236598 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4220650896 |
| primary_location.source.issn | 2755-0834 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2755-0834 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Journal of Medicine Access |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/27550834241236598 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Journal of Medicine Access |
| primary_location.landing_page_url | https://doi.org/10.1177/27550834241236598 |
| publication_date | 2024-01-01 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3199366111, https://openalex.org/W4387310672, https://openalex.org/W3204693682, https://openalex.org/W2112687036, https://openalex.org/W2143785588, https://openalex.org/W2060209969, https://openalex.org/W2617335911, https://openalex.org/W4214671382, https://openalex.org/W2886440016, https://openalex.org/W1847314269, https://openalex.org/W4293197298, https://openalex.org/W2554416008, https://openalex.org/W2319250829, https://openalex.org/W2626629817, https://openalex.org/W2921995610, https://openalex.org/W2261406464, https://openalex.org/W3121530490, https://openalex.org/W3044001844, https://openalex.org/W2994640210, https://openalex.org/W2122992752, https://openalex.org/W2751735789, https://openalex.org/W3025355178, https://openalex.org/W4312018758, https://openalex.org/W2590690511, https://openalex.org/W2902283514, https://openalex.org/W2967184466, https://openalex.org/W2554256565, https://openalex.org/W4323652315, https://openalex.org/W2408265127, https://openalex.org/W4306909282, https://openalex.org/W2902487979, https://openalex.org/W3042132004, https://openalex.org/W2148971244, https://openalex.org/W4210465547, https://openalex.org/W3094101325, https://openalex.org/W3089589232, https://openalex.org/W2161374186, https://openalex.org/W2507395187, https://openalex.org/W2141757546, https://openalex.org/W3110757045, https://openalex.org/W4386288999, https://openalex.org/W2231297534, https://openalex.org/W4381245404, https://openalex.org/W2004206184, https://openalex.org/W2345438034, https://openalex.org/W2401773418, https://openalex.org/W2143145645, https://openalex.org/W2790185890, https://openalex.org/W2061622222, https://openalex.org/W2133825501, https://openalex.org/W278766995, https://openalex.org/W4245504253, https://openalex.org/W2054721365, https://openalex.org/W1974175429, https://openalex.org/W1957980836, https://openalex.org/W1987354245, https://openalex.org/W2415846806, https://openalex.org/W1516450049, https://openalex.org/W2144197994, https://openalex.org/W1992119263, https://openalex.org/W2577316830, https://openalex.org/W2002980572, https://openalex.org/W1520241580, https://openalex.org/W2156120432, https://openalex.org/W2992456737, https://openalex.org/W2105893320, https://openalex.org/W2122047846, https://openalex.org/W4292482657, https://openalex.org/W2990873785, https://openalex.org/W4292121757, https://openalex.org/W2544151593, https://openalex.org/W2123531276, https://openalex.org/W2979186816, https://openalex.org/W2009016133, https://openalex.org/W3123623274, https://openalex.org/W2057965941, https://openalex.org/W3041104619, https://openalex.org/W2170630928, https://openalex.org/W2410888153, https://openalex.org/W2529705361, https://openalex.org/W2029489376, https://openalex.org/W2940096385, https://openalex.org/W3125709941, https://openalex.org/W2151675760, https://openalex.org/W4223909321, https://openalex.org/W2883048514, https://openalex.org/W3000230954, https://openalex.org/W3048872753, https://openalex.org/W4309961181, https://openalex.org/W4377107816, https://openalex.org/W4318590264, https://openalex.org/W2884982112, https://openalex.org/W3107173128, https://openalex.org/W2067169045, https://openalex.org/W1668247097, https://openalex.org/W2811169424, https://openalex.org/W3150905933, https://openalex.org/W2005503002, https://openalex.org/W2549639199, https://openalex.org/W4210599177, https://openalex.org/W2775603476, https://openalex.org/W2126365974, https://openalex.org/W2890315343, https://openalex.org/W2470689406 |
| referenced_works_count | 104 |
| abstract_inverted_index.a | 45, 75, 94, 106, 127, 222 |
| abstract_inverted_index.SF | 38, 122, 149, 158, 206, 234, 252 |
| abstract_inverted_index.To | 24 |
| abstract_inverted_index.We | 43, 53 |
| abstract_inverted_index.as | 105 |
| abstract_inverted_index.be | 210 |
| abstract_inverted_index.by | 73 |
| abstract_inverted_index.in | 21, 40, 57, 84, 97, 100, 124, 212, 216, 219 |
| abstract_inverted_index.is | 92, 141, 225, 264 |
| abstract_inverted_index.it | 263 |
| abstract_inverted_index.of | 10, 28, 37, 68, 112, 148, 194, 273 |
| abstract_inverted_index.on | 49 |
| abstract_inverted_index.to | 4, 88, 117, 130, 136, 139, 153, 202, 229, 266 |
| abstract_inverted_index.Web | 67 |
| abstract_inverted_index.all | 290 |
| abstract_inverted_index.and | 7, 12, 70, 102, 120, 161, 181, 190, 204, 237, 259, 279, 284, 287 |
| abstract_inverted_index.are | 16 |
| abstract_inverted_index.can | 32, 156, 196, 232 |
| abstract_inverted_index.for | 108, 145, 168, 187 |
| abstract_inverted_index.how | 29 |
| abstract_inverted_index.is, | 240 |
| abstract_inverted_index.the | 26, 34, 58, 109, 142, 146, 164, 213, 274 |
| abstract_inverted_index.use | 193, 257 |
| abstract_inverted_index.(SF) | 14 |
| abstract_inverted_index.Both | 1 |
| abstract_inverted_index.drug | 188 |
| abstract_inverted_index.from | 61 |
| abstract_inverted_index.need | 126 |
| abstract_inverted_index.next | 110 |
| abstract_inverted_index.that | 173, 239 |
| abstract_inverted_index.this | 85 |
| abstract_inverted_index.use, | 238 |
| abstract_inverted_index.use. | 162 |
| abstract_inverted_index.were | 82 |
| abstract_inverted_index.will | 103 |
| abstract_inverted_index.with | 289 |
| abstract_inverted_index.based | 48 |
| abstract_inverted_index.care. | 114 |
| abstract_inverted_index.chain | 167, 269 |
| abstract_inverted_index.could | 174 |
| abstract_inverted_index.goals | 20 |
| abstract_inverted_index.local | 249 |
| abstract_inverted_index.major | 95, 143 |
| abstract_inverted_index.price | 183 |
| abstract_inverted_index.still | 93 |
| abstract_inverted_index.surge | 36 |
| abstract_inverted_index.their | 132 |
| abstract_inverted_index.trade | 171 |
| abstract_inverted_index.unmet | 17 |
| abstract_inverted_index.used. | 226 |
| abstract_inverted_index.using | 74, 177 |
| abstract_inverted_index.Access | 87 |
| abstract_inverted_index.Africa | 101, 125, 220 |
| abstract_inverted_index.Google | 71 |
| abstract_inverted_index.access | 3, 31, 116, 138, 152, 201, 228, 242 |
| abstract_inverted_index.answer | 25 |
| abstract_inverted_index.cannot | 209 |
| abstract_inverted_index.chain, | 276 |
| abstract_inverted_index.decade | 111 |
| abstract_inverted_index.ensure | 137 |
| abstract_inverted_index.entire | 165 |
| abstract_inverted_index.entry, | 254 |
| abstract_inverted_index.health | 18, 113 |
| abstract_inverted_index.period | 215 |
| abstract_inverted_index.query. | 78 |
| abstract_inverted_index.reason | 144 |
| abstract_inverted_index.reduce | 33, 157, 175, 233 |
| abstract_inverted_index.review | 47 |
| abstract_inverted_index.search | 77 |
| abstract_inverted_index.sector | 19 |
| abstract_inverted_index.supply | 166, 268, 275 |
| abstract_inverted_index.threat | 107 |
| abstract_inverted_index.unless | 221 |
| abstract_inverted_index.Africa. | 22, 41 |
| abstract_inverted_index.Design: | 42 |
| abstract_inverted_index.Embase, | 65 |
| abstract_inverted_index.English | 59 |
| abstract_inverted_index.Failure | 135 |
| abstract_inverted_index.Scholar | 72 |
| abstract_inverted_index.Scopus, | 66 |
| abstract_inverted_index.access, | 176 |
| abstract_inverted_index.access. | 198 |
| abstract_inverted_index.address | 131, 271 |
| abstract_inverted_index.causes. | 134 |
| abstract_inverted_index.improve | 197, 267, 277 |
| abstract_inverted_index.planned | 214 |
| abstract_inverted_index.problem | 96 |
| abstract_inverted_index.quality | 89, 118, 154, 230 |
| abstract_inverted_index.review. | 86 |
| abstract_inverted_index.scoping | 46 |
| abstract_inverted_index.supply, | 245 |
| abstract_inverted_index.system, | 258 |
| abstract_inverted_index.through | 243 |
| abstract_inverted_index.Cochrane | 63 |
| abstract_inverted_index.Ensuring | 115, 200 |
| abstract_inverted_index.Library, | 64 |
| abstract_inverted_index.Methods: | 52 |
| abstract_inverted_index.Results: | 79 |
| abstract_inverted_index.Science, | 69 |
| abstract_inverted_index.achieved | 211 |
| abstract_inverted_index.approach | 129 |
| abstract_inverted_index.articles | 55, 81 |
| abstract_inverted_index.avoiding | 170 |
| abstract_inverted_index.continue | 104 |
| abstract_inverted_index.control, | 184 |
| abstract_inverted_index.enhanced | 248 |
| abstract_inverted_index.ensuring | 241 |
| abstract_inverted_index.improved | 30, 246, 255, 260 |
| abstract_inverted_index.included | 83 |
| abstract_inverted_index.language | 60 |
| abstract_inverted_index.medicine | 159, 207, 235, 253 |
| abstract_inverted_index.question | 27 |
| abstract_inverted_index.rational | 192 |
| abstract_inverted_index.relevant | 291 |
| abstract_inverted_index.searched | 54 |
| abstract_inverted_index.standard | 50 |
| abstract_inverted_index.strategy | 224 |
| abstract_inverted_index.Improving | 151, 227 |
| abstract_inverted_index.conducted | 44 |
| abstract_inverted_index.countries | 99, 218 |
| abstract_inverted_index.essential | 5, 90, 265 |
| abstract_inverted_index.establish | 281 |
| abstract_inverted_index.falsified | 13 |
| abstract_inverted_index.licensing | 179 |
| abstract_inverted_index.marketing | 9, 160, 208, 236 |
| abstract_inverted_index.medicines | 6, 15, 39, 91, 119, 123, 140, 155, 195, 203, 231 |
| abstract_inverted_index.promoting | 191 |
| abstract_inverted_index.protocol. | 51 |
| abstract_inverted_index.providing | 185 |
| abstract_inverted_index.published | 56 |
| abstract_inverted_index.Objective: | 23 |
| abstract_inverted_index.Therefore, | 262 |
| abstract_inverted_index.agreements | 172 |
| abstract_inverted_index.challenges | 272 |
| abstract_inverted_index.combatting | 8 |
| abstract_inverted_index.compulsory | 178 |
| abstract_inverted_index.continuous | 35 |
| abstract_inverted_index.developing | 98, 217 |
| abstract_inverted_index.incentives | 186 |
| abstract_inverted_index.leadership | 278 |
| abstract_inverted_index.medication | 256 |
| abstract_inverted_index.medicines. | 150 |
| abstract_inverted_index.preventing | 121, 205, 251 |
| abstract_inverted_index.systematic | 76, 128 |
| abstract_inverted_index.underlying | 133 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Conclusion: | 199 |
| abstract_inverted_index.Seventy-one | 80 |
| abstract_inverted_index.capability, | 270 |
| abstract_inverted_index.collaborate | 288 |
| abstract_inverted_index.committees, | 286 |
| abstract_inverted_index.constrained | 2 |
| abstract_inverted_index.efficiency, | 169, 247 |
| abstract_inverted_index.governance, | 280 |
| abstract_inverted_index.production, | 250 |
| abstract_inverted_index.provisions, | 180 |
| abstract_inverted_index.substandard | 11 |
| abstract_inverted_index.Manipulating | 163 |
| abstract_inverted_index.availability | 147 |
| abstract_inverted_index.development, | 189 |
| abstract_inverted_index.comprehensive | 223 |
| abstract_inverted_index.stakeholders. | 292 |
| abstract_inverted_index.uninterrupted | 244 |
| abstract_inverted_index.affordability. | 261 |
| abstract_inverted_index.pharmaceutical | 182 |
| abstract_inverted_index.PubMed/Medline, | 62 |
| abstract_inverted_index.country-specific | 282 |
| abstract_inverted_index.anti-counterfeiting | 283 |
| abstract_inverted_index.anti-substandardization | 285 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5069670534 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 3 |
| corresponding_institution_ids | https://openalex.org/I2801278263 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/17 |
| sustainable_development_goals[0].score | 0.5299999713897705 |
| sustainable_development_goals[0].display_name | Partnerships for the goals |
| citation_normalized_percentile.value | 0.96123213 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |